DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C4721610 | Carcinoma, Ovarian Epithelial | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C1332986 | Childhood Osteosarcoma | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0242379 | Malignant neoplasm of lung | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0025500 | Mesothelioma | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C2930619 | Sex Differentiation Disorders | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0149925 | Small cell carcinoma of lung | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0000768 | Congenital Abnormality | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0014173 | Endometrial Hyperplasia | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0399378 | Dentinogenesis imperfecta - Shield's type III (disorder) | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0014175 | Endometriosis | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C1961099 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C1458155 | Mammary Neoplasms | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C1140680 | Malignant neoplasm of ovary | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0023895 | Liver diseases | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0024305 | Lymphoma, Non-Hodgkin | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0033578 | Prostatic Neoplasms | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C2239176 | Liver carcinoma | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0011430 | Dentin Dysplasia | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0007137 | Squamous cell carcinoma | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0476089 | Endometrial Carcinoma | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0269102 | Endometrioma | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0005684 | Malignant neoplasm of urinary bladder | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0279626 | Squamous cell carcinoma of esophagus | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0009081 | Congenital clubfoot | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
C0919267 | ovarian neoplasm | AKR1C1 | 1645 | aldo-keto reductase family 1 member C1 | Q04828 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024